Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]

Synthèse documentaire ASEM

Document officiel de National Advisory Committee on Immunization (2021) sur « Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] ». Extrait officiel (langue source) : NACI recommendations on the use of the Pfizer-BioNTech COVID-19 vaccine in children 5 to 11 years of age: Background, methods, summary of evidence, research priorities, acknowledgments, abbreviations and frequency of solicited adverse events following immunization for COVID-19 in clinical trials. Consultez la publication officielle pour les recommandations détaillées et leur champ d’application.

Cette synthèse facilite le repérage du document. Pour les recommandations cliniques, consultez toujours la version officielle et sa date de mise à jour.